Entering text into the input field will update the search result below

Fresh Start Private Management Inc. (CEYY) Signs Contract with Aetna Health Management LLC for Approval of Its Alcohol Treatment Program

Apr. 20, 2011 2:29 PM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2008

QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net.

Fresh Start Private Management Inc., a company that strives through the alcohol treatment and rehabilitation industry, has announced that its alcohol treatment procedure has entered a contract with Aetna Health Management, LLC Individual and Family Plan Underwriting Department in order to gain approval for its alcohol treatment program.

Aetna Health Management, Inc. is a subsidiary of Aetna Health Holdings, LLC. Per terms of the contract, there is a commitment for prompt payment from the insurance company.

Fresh Start Private continues its journey to create a successful business model that enables its patients to be underwritten by their insurance companies; which in turn increases the market potential for its services for the 13.8 million Americans who suffer with problems from drinking, which includes the 8.1 million people who are suffering from alcoholism. The number of people treated for alcoholism has reached approximately 950,000 per year.

As previously announced by Fresh Start, the company continues to work with Blue Cross, Kaiser, Healthnet, CIGNA, United Healthcare, Anthem, SSI, Tri-West, MSI, and Presbyterian in order to have more patients approved for treatment for its cutting edge Naltrexone implant.

A spokesperson stated, “Aggressive, eye-level marketing is now being followed by direct sales that include a mix of tactics including building partnerships and developing new sales leads. With revenue potentials of up to $120 million a clinic, our goal is to be become the leader in alcohol treatment in the United States.”

Fresh Start Private Management Inc. is an alcohol addiction, alcohol withdrawal, treatment for alcohol abuse and detox rehabilitation company, leading on the edge of alcohol addiction treatment. The company offers extensive experience in alcohol addiction treatment, as it has successfully treated over 5,000 addiction patients for both drugs and alcohol. The company has created a comprehensive alcohol treatment program that includes all of the essential elements needed for a successful recovery.

For more information on Fresh Start Private and their extensive rehabilitation program, visit their company website at freshstartprivate.com

Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.